Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities
Oncogenic driver mutations in lung cancer, Translational Respiratory Medicine
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
Unique Genetic Characteristics and Clinical Prognosis of Female Patients with Lung Cancer Harboring RET Fusion Gene
PDF) Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
Susumu Kobayashi on LinkedIn: #cancerresearch #cancertreatment #lungcancer
Frontiers Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC
Expression of LTK constructs in 293T cells. (A) Relative protein
PDF) Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver
Tadashi Manabe MD, PhD on X: A whole new oncogenic driver in non-small-cell lung cancer found by the LC-SCRUM Asia. Very very impressive! / X
Member Detail - DF/HCC
Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma
